9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022
复制标题

DOI:
10.2337/dc22-s009
复制
发表时间:
2022-01-01
期刊:
影响因子:
16.2
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

被引文献

相似文献

美国糖尿病协会(ADA)“糖尿病医疗护理标准”包括ADA当前的临床实践建议,旨在提供糖尿病护理的组成部分、一般治疗目标和指南以及评估护理质量的工具。ADA专业实践委员会是一个多学科专家委员会(https://doi.org/10.2337/dc22-SPPC),其成员负责每年更新护理标准,或根据需要更频繁地更新。有关ADA标准、声明和报告的详细描述,以及ADA临床实践建议的证据分级系统,请参阅护理标准简介(https://doi.org/10.2337/dc22-SINT)。希望对护理标准发表评论的读者请访问professional.diabetes.org/SOC。
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.